Gregory T. Lucier Buys 15,142 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory T. Lucier acquired 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

DENTSPLY SIRONA Trading Down 3.4 %

Shares of XRAY stock opened at $15.99 on Tuesday. The stock’s fifty day simple moving average is $18.83 and its 200 day simple moving average is $21.46. DENTSPLY SIRONA Inc. has a twelve month low of $15.94 and a twelve month high of $34.28. The firm has a market capitalization of $3.18 billion, a P/E ratio of -7.72, a P/E/G ratio of 1.80 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.00%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Analyst Ratings Changes

XRAY has been the subject of several recent research reports. Robert W. Baird reduced their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday. Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 17th. Mizuho assumed coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price objective on the stock. Evercore ISI reaffirmed an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Finally, Needham & Company LLC dropped their price target on DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating for the company in a research note on Friday. Eleven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $23.58.

Institutional Trading of DENTSPLY SIRONA

Institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock valued at $383,078,000 after purchasing an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC lifted its holdings in shares of DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock worth $275,218,000 after purchasing an additional 348,532 shares in the last quarter. Nuance Investments LLC grew its holdings in shares of DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock valued at $257,103,000 after buying an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after purchasing an additional 1,975,404 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock worth $219,018,000 after buying an additional 314,343 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.